Haroun Gajraj: Stop Before You Inject Spider Veins Around the Ankle
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, posted on LinkedIn:
“STOP: BEFORE YOU INJECT SPIDER VEINS AROUND THE ANKLE…
Consider these 4…
The ankle region is one of the RISKIEST areas in Sclerotherapy.
Even experienced practitioners can face complications that lead to months of patient pain.
Here are the 4 crucial factors that make this zone a clinical minefield:
1. Arterial Vulnerability
This zone is uniquely prone to inadvertent injection into tiny arterioles, or sometimes arteries, with potentially disastrous consequences.
2. Protracted Pain
Extravasation of sclerosant can easily inflame a superficial sensory nerve, leading to sharp pain that persists for weeks, and often months.
3. Slow Healing
Any resulting scabs or skin ulcers typically take a considerably longer time to heal compared to other areas of the leg.
4. Venous Reflux
Spider veins here are more strongly associated with underlying venous reflux, meaning superficial treatment alone may not address the root cause.
If you are treating this area, you must know the correct technique and mitigation strategies to protect your patient and your practice.
I have shared my full approach and detailed advice in a video. Watch the expert technique and full warning here.
I’m REALLY interested to hear from other experienced specialists.
For experienced practitioners: Which specific sclerosant and concentration do you prefer for the ankle, and why?
Let’s discuss best practices in the comments!
Acknowledgment: Injection technique demonstrated by Zola Mzimba board member of The British Association of Sclerotherapists
Disclaimer
- This content is for educational purposes only and is intended for medical professionals (Sclerotherapists, Phlebologists, etc.). It does not constitute specific medical advice, diagnosis, or treatment for any individual. Always rely on your own clinical judgment, training, and patient assessment before performing procedures.”

Stay informed with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch